Medications for Granulomatosis With Polyangiitis

3 results

  • Rituxan

    (rituximab)
    Genentech, Inc.
    Usage: RITUXAN is indicated for the treatment of various conditions including Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Pemphigus Vulgaris (PV) in adults and pediatric patients, as specified.

  • Ruxience

    (rituximab-pvvr)
    Pfizer Laboratories Div Pfizer Inc
    Usage: RUXIENCE is indicated for adult patients with relapsed or refractory non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and granulomatosis with polyangiitis and microscopic polyangiitis, often in combination with other therapies, depending on the specific condition and patient response.

  • Tavneos

    (avacopan)
    ChemoCentryx, Inc.
    Usage: TAVNEOS is indicated as an adjunctive treatment for adults with severe active ANCA-associated vasculitis, specifically granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), when used alongside standard therapy, including glucocorticoids. It does not replace glucocorticoid use.